A recent JAMA Psychiatry study found that an ADHD medicine called lisdexamfetamine reduced the risk of hospitalization due to amphetamine or methamphetamine addiciton by 18% and 14% for deaths caused by substance abuse disorders.
Subscribe to:
Post Comments (Atom)
< + > Are You Experiencing Data Chaos or Clean Identity with Your EMPI?
Identity management is one of the most challenging problems healthcare IT organizations face. For those not familiar with identity manageme...
No comments:
Post a Comment